http://www.fpnotebook.com/
Narcolepsy
Aka: Narcolepsy
- Epidemiology
- Prevalence: 40 per 100,000 (0.02 to 0.18% of adults)
- Men and women affected equally
- Onset in adolescence
- Pathophysiology
- Excessive Sleepiness
- Abnormal REM Sleep
- Causes
- Idiopathic
- Hereditary related to DR-2
- Secondary causes
- Head Trauma
- Encephalopathy
- Brain Tumor
- Cerebrovascular insufficiency
- Symptoms
- Recurrent irresistible Daytime Sleepiness
- Occurs unexpectedly and at inappropriate times
- Cataplexy (25-30% of patients with Narcolepsy)
- Brief episodic muscular paralysis
- Provocative factors
- Emotional events
- Differential Diagnosis
- See Hypersomnolence
- Sleep Apnea
- Other Primary Hypersomnia (uncommon)
- Idiopathic Hypersomnia
- Menstrual Hypersomnia
- Kleine-Levin Syndrome (rare syndrome of male teens)
- Evaluation
- See Hypersomnolence
- Diagnosis: Sleep Study
- Shortened REM latency
- Rapid transition to REM
- Management: Standard Medications (Risk of dependence)
- See Hypersomnia
- Modafinil (Provigil)
- Best safety profile and lowest abuse potential of all stimulant agents
- Methylphenidate (Ritalin)
- Dextroamphetamine (Dexedrine)
- References
- Billiard (2008) Neuropsychiatr Dis Treat 4(3):557-66
- Pagel (2009) Am Fam Physician 79(5): 391-6
- Thorpy (2006) CNS Drugs 20(1): 43-50